SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-18-015850
Filing Date
2018-06-20
Accepted
2018-06-20 08:45:20
Documents
10
Period of Report
2018-06-15
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K achv-8k_20180615.htm 8-K 52871
2 EX-1.1 achv-ex11_9.htm EX-1.1 633556
3 EX-3.1 achv-ex31_8.htm EX-3.1 132969
4 EX-4.1 achv-ex41_245.htm EX-4.1 141960
5 EX-4.2 achv-ex42_33.htm EX-4.2 49736
6 EX-99.1 achv-ex991_7.htm EX-99.1 12248
7 EX-99.2 achv-ex992_6.htm EX-99.2 10099
8 GRAPHIC g201806200608270919013.jpg GRAPHIC 2203
9 GRAPHIC g201806200608157108588.jpg GRAPHIC 56566
10 GRAPHIC g201806200608297709014.jpg GRAPHIC 2203
  Complete submission text file 0001564590-18-015850.txt   1119371
Mailing Address 520 PIKE STREET SUITE 2250 SEATTLE WA 98101
Business Address 520 PIKE STREET SUITE 2250 SEATTLE WA 98101 425-686-1500
ACHIEVE LIFE SCIENCES, INC. (Filer) CIK: 0000949858 (see all company filings)

IRS No.: 954343413 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 033-80623 | Film No.: 18908708
SIC: 2835 In Vitro & In Vivo Diagnostic Substances